EcoDrugPlus

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSGACG00000020783
Gene Symbol: GRIA4B
1 Cross references
252 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSGACG00000018121
Gene Symbol: GRIN1A
1 Cross references
203 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSGACG00000015979
Gene Symbol: GRIN2BB
1 Cross references
256 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSGACG00000010427
Gene Symbol: GRM2B
1 Cross references
210 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSGACG00000012733
Gene Symbol: GRM3
1 Cross references
212 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSGACG00000020586
Gene Symbol: GRM5A
1 Cross references
212 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSGACG00000007968
Gene Symbol: GRM5B
1 Cross references
216 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSGACG00000015599
Gene Symbol: GLSA
1 Cross references
236 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSGACG00000001987
Gene Symbol: GSK3AA
1 Cross references
181 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSGACG00000009447
Gene Symbol: GSK3AB
1 Cross references
187 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSGACG00000003629
Gene Symbol: GSK3BA
1 Cross references
208 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor 1

Ensembl ID : ENSGACG00000000507
Gene Symbol: GNRHR1
2 Cross references
174 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).